1Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt
2Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia
3PharmD candidate, Taif, Saudi Arabia
4Dermatology specialist, Ministry of Health, Egypt
Journal of Cancer Research and Treatment.
2016,
Vol. 4 No. 6, 96-98
DOI: 10.12691/jcrt-4-6-1
Copyright © 2016 Science and Education PublishingCite this paper: Ahmed M. Kabel, Ali Y. Alghubayshi, Fatma M. Moharm. The Impact of Polycystic Ovarian Syndrome, a Potential Risk Factor to Endometrial Cancer, on the Quality of Sleep.
Journal of Cancer Research and Treatment. 2016; 4(6):96-98. doi: 10.12691/jcrt-4-6-1.
Correspondence to: Ahmed M. Kabel, Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt. Email:
drakabel@gmail.comAbstract
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women during their reproductive age. Recent studies showed that PCOS may be a risk factor to the development of endometrial cancer. This risk factor may be associated with sleep disorders including sleep-disordered breathing and excessive daytime sleepiness. The mechanisms leading to this high prevalence of sleep disorders in PCOS have not yet been identified. However, possible causes include alterations in body fat composition due to excess androgen levels and/or the effects of the metabolic syndrome. These effects on sleep disorders may have an impact on daily physical activities.
Keywords